Target Details
| UniProt AC | Q14164 |
|---|---|
| Gene Symbol | IKBKE |
| Protein Name | Inhibitor of nuclear factor kappa-B kinase subunit epsilon |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) PF18394 (TBK1_CCD1) PF18396 (TBK1_ULD) |
Summary
- Multi-target molecules 596
- Clinical molecules 14
- Avg pChEMBL 7.38
KEGG Pathways (18)
- Alcoholic liver disease
- C-type lectin receptor signaling pathway
- Chemical carcinogenesis - receptor activation
- Coronavirus disease - COVID-19
- Cytosolic DNA-sensing pathway
- Epstein-Barr virus infection
- Hepatitis B
- Hepatitis C
- Herpes simplex virus 1 infection
- Human papillomavirus infection
- IL-17 signaling pathway
- Influenza A
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- NOD-like receptor signaling pathway
- RIG-I-like receptor signaling pathway
- Toll-like receptor signaling pathway
Active Molecules (596)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
FEPKNBFNXRIIAB
|
6.2 | IC50 | 2 | — | |
HWXVIOGONBBTBY
|
6.2 | Kd | 27 | — | |
KTEIFNKAUNYNJU
|
6.2 | Kd | 114 | — | |
WNLZXWKRUIEXHK
|
6.1 | IC50 | 2 | — | |
BUOPARGTGBRMBL
|
6.1 | IC50 | 2 | — | |
FFPHMUIGESPOTK
|
6.1 | IC50 | 6 | — | |
CJNKBAKWQGYGIS
|
6.1 | IC50 | 4 | — | |
FUMCKNCUEAQHCV
|
6.1 | Ki | 103 | — | |
HDRLAVNNWSHSOA
|
6.1 | Ki | 19 | — | |
NKEUPUJTVALZIK
|
6.1 | Ki | 28 | — | |
RYYNGWLOYLRZLK
|
6.1 | Kd | 45 | — | |
UJBJWYNPUOLFIZ
|
6.1 | Ki | 49 | — | |
FXOQQOTXASSILN
|
6.1 | IC50 | 2 | — | |
KGMZRZBOGQECSK
|
6.1 | IC50 | 2 | — | |
IVAFRTWUCSWUMI
|
6.1 | IC50 | 2 | — | |
LTKDDAVQVRFMKQ
|
6.1 | IC50 | 2 | — | |
XNLQEOMWHKGKJO
|
6.0 | IC50 | 2 | — | |
YFHGVXAURSKWLJ
|
6.0 | IC50 | 2 | — | |
BBJKFMYLMLVUDU
|
6.0 | IC50 | 2 | — | |
FQLDODIEEKFQOP
|
6.0 | IC50 | 2 | — | |
HIONSSOVORAGDX
|
6.0 | IC50 | 2 | — | |
BWUXLVAYVBIOEY
|
6.0 | IC50 | 2 | — | |
CJKXRJUXLJTCRE
|
6.0 | IC50 | 3 | — | |
DFMCXVONDDGQIY
|
6.0 | Ki | 66 | — | |
DFZQZSMWFHQAPD
|
6.0 | IC50 | 2 | — | |
DSXDCHYXQFEFIC
|
6.0 | IC50 | 2 | — | |
FBBJGFHGYDVTLK
|
6.0 | IC50 | 3 | — | |
FEWKHURGVUMFHP
|
6.0 | IC50 | 2 | — | |
HSBRJCXMRYCUJI
|
6.0 | IC50 | 2 | — | |
HZPACYSNLOCDLW
|
6.0 | Ki | 48 | — | |
IVVSBEQDCAZLFY
|
6.0 | IC50 | 333 | — | |
KHVVJKLNKLQLJZ
|
6.0 | IC50 | 288 | — | |
KUMKJWMPOOYVGT
|
6.0 | IC50 | 2 | — | |
LHXLDDHQDUKPIM
|
6.0 | IC50 | 3 | — | |
LXKLPOKJWLBIKC
|
6.0 | IC50 | 2 | — | |
MAHFVAHPQSLLJF
|
6.0 | IC50 | 288 | — | |
MDJWRQAHXDUJLV
|
6.0 | IC50 | 3 | — | |
MRUJTDMRVPXECC
|
6.0 | IC50 | 2 | — | |
NECQZMQPXFYVOY
|
6.0 | Ki | 26 | — | |
OMWKEJOTYAGCFP
|
6.0 | IC50 | 2 | — | |
QQWUGDVOUVUTOY
|
6.0 | Ki | 231 | Yes | |
QTBWCSQGBMPECM
|
6.0 | Kd | 21 | Yes | |
QZLCSJKQXXMWTE
|
6.0 | IC50 | 2 | — | |
WQFGNANQTYLQBP
|
6.0 | Ki | 16 | — | |
WVQCAVLGAOTNQE
|
6.0 | IC50 | 2 | — | |
ZCCJKVBTHCOISJ
|
6.0 | Ki | 46 | — |